STATE TIMES NEWS
NEW DELHI: Prime Minister Narendra Modi will interact with chief ministers of all states on January 11 to discuss the COVID-19 situation and the vaccination roll-out in the country, his office said on Friday.
This will be Modi’s first interaction with chief ministers following the recent approval of two coronavirus vaccines for restricted emergency use by India’s drug regulator.
The prime minister has often spoken with state chief ministers following the pandemic’s outbreak in the country.
India is preparing for the roll-out of COVID-19 vaccines and the second nationwide mock drill on the drive was conducted on Friday.
India’s drugs regulator has approved Oxford vaccine Covishield, being manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.
Ahead of the COVID-19 vaccines roll-out, the Ministry of External Affairs this afternoon said Prime Minister Narendra Modi’s announcement that India’s vaccine production and delivery capacity would be used for the benefit of all humanity in fighting this crisis needs to be noted.
Asked about the issue of supply of vaccines to neighbouring countries and other nations, Ministry of External Affairs (MEA) spokesperson Anurag Srivastava said India has been at the forefront of the global response in this common fight against the COVID-19 pandemic.
India sees international cooperation in this field, particularly with its neighbours, as its duty, he said at an online media briefing.
“You would be aware that in our neighbourhood, we have already provided medicines and other essential supplies. We have held training sessions for experts from these countries on vaccine-related issues,” he said.
“As we roll out vaccines, Prime Minister’s announcement that India’s vaccine production and delivery capacity would be used for the benefit of all humanity in fighting this crisis needs to be noted,” Srivastava said,
The remarks came on a day Union Health and Family Welfare Minister Harsh Vardhan said soon it would be a reality to vaccinate the entire population in the country against COVID-19 after prioritising risk groups.
The Drugs Controller General of India (DCGI) had on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.